Correlation Between ProKidney Corp and Novo Nordisk

Can any of the company-specific risk be diversified away by investing in both ProKidney Corp and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ProKidney Corp and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ProKidney Corp and Novo Nordisk AS, you can compare the effects of market volatilities on ProKidney Corp and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ProKidney Corp with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of ProKidney Corp and Novo Nordisk.

Diversification Opportunities for ProKidney Corp and Novo Nordisk

0.19

Correlation Coefficient

ProKidney Corp  Novo Nordisk

Average diversification

The 3 months correlation between ProKidney and Novo is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding ProKidney Corp and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and ProKidney Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProKidney Corp are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of ProKidney Corp i.e., ProKidney Corp and Novo Nordisk go up and down completely randomly.

Pair Corralation between ProKidney Corp and Novo Nordisk

Given the investment horizon of 90 days ProKidney Corp is expected to generate 1.41 times more return on investment than Novo Nordisk. However, ProKidney Corp is 1.41 times more volatile than Novo Nordisk AS. It trades about -0.13 of its potential returns per unit of risk. Novo Nordisk AS is currently generating about -0.27 per unit of risk. If you would invest  205.00  in ProKidney Corp on October 12, 2024 and sell it today you would lose (39.00) from holding ProKidney Corp or give up 19.02% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

ProKidney Corp  vs.  Novo Nordisk AS

ProKidney Corp

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in ProKidney Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, ProKidney Corp may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Novo Nordisk AS

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with ProKidney Corp and Novo Nordisk

The main advantage of trading using opposite ProKidney Corp and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ProKidney Corp position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.

The idea behind ProKidney Corp and Novo Nordisk AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.